GL1X · GenesisL1 explorer

MolNFT v1 · #60021 · protein

Crystal structure of purple-fluorescent antibody EP2-25C10

3CFE · Purple-fluorescent antibody EP2-25C10-kappa light chain: “Crystal structure of purple-fluorescent antibody EP2-25C10”. X-ray diffraction, 1 ligand (SO4), 11 pockets (best druggability 0.63). MolNFT v1 #60021 on GenesisL1: 3D…

PDB
3CFE
Type
protein
Length
864 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Purple-fluorescent antibody EP2-25C10-kappa light chain; Purple-fluorescent antibody…
Ligands
SO4
Pockets
11 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
L, APurple-fluorescent antibody EP2-25C10-kappa light chainprotein2136% helix, 51% strand—
H, BPurple-fluorescent antibody EP2-25C10-IGG2B heavy chainprotein2194% helix, 55% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 5 copies · chains A, L, H, B
  • GOL · Glycerol · additive · 3 copies · chains H, L, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11110.630.8827empty
21090.620.8724empty
33740.560.7549empty
42440.510.7635empty
51980.490.7638empty

Interfaces

2 interfaces between chains.

  • L–H · 1870 Ų buried · 17 hydrogen bonds · protein-protein
  • A–B · 1854 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 3CFE · Crystal structure of purple-fluorescent antibody EP2-25C10 · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.